BRIEF-Labcorp Completes Acquisition Of Select Assets Of BioReference Health's Innovative Oncology And Related Clinical Testing Services Businesses-March 2024-www.financetom.com

BRIEF-Labcorp Completes Acquisition Of Select Assets Of BioReference Health's Innovative Oncology And Related Clinical Testing Services Businesses

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Labcorp Completes Acquisition Of Select Assets Of BioReference Health's Innovative Oncology And Related Clinical Testing Services Businesses

Sep 15, 2025 6:35 PM

Sept 15 (Reuters) - Labcorp Holdings Inc ( LH ):

* LABCORP COMPLETES ACQUISITION OF SELECT ASSETS OF

BIOREFERENCE

HEALTH'S INNOVATIVE ONCOLOGY AND RELATED CLINICAL TESTING

SERVICES BUSINESSES

* LABCORP ( LH ): PURCHASE PRICE FOR TRANSACTION IS UP TO $225

MILLION

Source text:

Further company coverage:

Previous page： Sector Update: Consumer Next page： Walmart Lifts Fiscal 2025 Outlook Following First-Quarter Beat

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sector Update: Consumer

May 16, 2024

08:49 AM EDT, 05/16/2024 (MT Newswires) -- Consumer stocks were higher pre-bell Thursday as the Consumer Staples Select Sector SPDR Fund (XLP) was up 0.9% and the Consumer Discretionary Select Sector SPDR Fund (XLY) was advancing 0.3%. Walmart ( WMT ) shares rose past 6% after the company reported higher fiscal Q1 adjusted earnings and revenue. The company also said...

Walmart Lifts Fiscal 2025 Outlook Following First-Quarter Beat

May 16, 2024

08:46 AM EDT, 05/16/2024 (MT Newswires) -- Walmart ( WMT ) on Thursday recorded better-than-expected fiscal first-quarter results buoyed by gains across all operating segments, prompting the retail giant to raise its full-year guidance. The company now anticipates to be at the high end or slightly above its original fiscal 2025 outlook for per-share adjusted earnings and sales growth. In...

Accenture Invests in AI-Focused Drug Interaction Simulation Startup Turbine

May 16, 2024

08:47 AM EDT, 05/16/2024 (MT Newswires) -- Accenture ( ACN ) said Thursday it has invested in Turbine, a firm focused on building an AI-powered human biology simulation platform meant to speed drug development. Financial terms of the investment weren't disclosed. Turbine will join an Accenture Ventures program aimed at providing startups with technological tools to develop their projects. Turbine's...

Seadrill to Sell 3 Jack-Up Rigs, 50% JV Stake in Qatar for $338 Million; Expands Share Buyback Program by $500 Million

May 16, 2024

08:03 AM EDT, 05/16/2024 (MT Newswires) -- Seadrill ( SDRL ) said Thursday it has agreed to sell its three jack-up rigs in Qatar and its 50% stake in a joint venture that operates the rigs to its JV partner Gulf Drilling International for $338 million in cash. In addition, Seadrill ( SDRL ) said its board has authorized the...